Font Size: a A A
Keyword [PD-1 Antibody]
Result: 21 - 40 | Page: 2 of 3
21. Efficacy And Safety Of PD-1 Antibody/PD-L1 Antibody Versus Chemotherapy In Advanced Non-small-cell Lung Cancer:a Meta-analysis
22. Anti-tumor Activity Of Anti-PD-1 Antibody In Lewis Lung Carcinoma Mouse Model
23. Study On The Effect And Mechanism Of Apatinib Alone And Combination With Anti-PD-1 Antibody In The Treatment Of Colon Cancer
24. Construction Of Recombinant Adenovirus Expressing Full-length PD-1 Antibody,Nivolumab
25. Investigation On The Immunotherapy Of Small Cell Lung Cancer By DLL3 Tareted Bispecifc Antibody And CAR-T
26. A Clinical Study Of Anti-PD-1 Antibody Combined With Pemetrexed As Second-or Further-line Treatment For Advanced Refractory Lung Adenocarcinoma
27. Mechanism Of Metformin Downregulates PD-L1 Expression In Esophageal Squamous Cell Carcinoma By Inhibiting IL-6 Signaling Pathway
28. Correlation Between Combined Fibrinogen And Neutrophil-lymphocyte Ratio And The Efficacy And Prognosis In Advanced Malignant Melanoma Patients Treated With Anti-PD-1 Antibody
29. Immunological Effect And Mechanism Of Nanosecond Pulse Ablation On Hepatocellular Carcinoma
30. Efficacy And Mechanism Study Of Anti-PD-1 Therapy Synergizing With Combretastatin A4 Nanoparticles Plus DC101 In Hepatocellular Carcinoma
31. The Efficacy Of Chemotherapy And Immunotherapy For Patients With Advanced Gastric Cancer And Colorectal Cancer And The Analyses Of Prognostic Factors
32. To Explore The Clinical Efficacy Of Paclitaxel Liposome And Nedaplatin In The Treatment Of Advanced Esophageal Carcinoma And The Clinical Characteristics Of Liver Dysfunction During The Treatment Of Combination Of Camrelizumab And Apatinib
33. Study On The Mechanism Of Gastric Cancer Mesenchymal Stem Cells Derived IL-8 Reducing The Efficacy Of Anti-PD-1 In Gastric Cancer
34. Manipulation Of TAMs Functions To Facilitate The Immune Therapy Effects Of PD-1 Antibody
35. Clinical Study Of Traditional Chinese Medicine Combined With Chemotherapy And PD-1 Antibodies In The Treatment Of Advanced NSCLC
36. A Clinical Study Of PD-1 Antibody Combined With Anlotinib In The Second-line Or Above Treatment Of Advanced Non-small Cell Lung Cancer
37. Application Of Novel Self-assembled Microspheres In Cancer Immunotherapy
38. Clinical Observation Of Skin-related Adverse Events Induced By Anti-PD-1 Antibody BGB-A317 In Patients With Solid Tumor
39. Therapeutic Effects Of IN Combination With Anti-PD-1 On Various Tumor Models In Mice
40. An Assessment Of Camrelizumab Combined With Chemotherapy In Metastatic Biliary Tract Cancers
  <<First  <Prev  Next>  Last>>  Jump to